{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:12:45Z","timestamp":1788786765116,"version":"build-2803163510"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30AR053503"],"award-info":[{"award-number":["P30AR053503"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Post-treatment Lyme Disease (PTLD) is a poorly understood complication of <jats:italic>Borrelia burgdorferi<\/jats:italic> infection with significant patient morbidity. Characterized by fatigue, generalized myalgias, and cognitive impairment, PTLD symptomatology closely resembles long COVID and other post-acute infection syndromes. While prior studies suggest immune dysregulation as a factor in PTLD pathogenesis, the mechanisms underlying its heterogeneous presentation and severity remain unclear. To associate symptom burden with discrete immune phenotypes, we applied factor analysis to self-reported symptom data from 272 PTLD patients to generate patient subgroups. We then immunophenotyped peripheral blood cells of these individuals and 28 healthy controls through 19-parameter flow cytometry and cytokine profiling to associate PTLD status and the newly defined subgroups with specific immune states. Our PTLD cohort had fewer circulating CXCR5+ CD4+ na\u00efve T cells relative to healthy controls (5.2% vs. 8.3%, Padj &amp;lt; 0.001). These cells were positively associated with musculoskeletal pain in PTLD participants, but not healthy controls. This and additional immunophenotypic alterations, including an increased prevalence of CXCR3+ CCR4- CCR6- CD8 T cells (43.1% vs. 25.7%, Padj &amp;lt; 0.01), permitted the creation of an elastic net classifier which identified PTLD with moderate efficacy (AUC 0.83). Measurement of cytokines did not reveal associations with PTLD and did not improve the performance of the model. While we could not identify immune features which distinguished all patient subgroups, we did observe a female-specific increase in central memory CD8 T cells restricted to one high-fatigue patient subgroup. Additionally, factor analysis revealed multiple associations between immune cell frequency and the severity of specific symptoms. Collectively, our findings add to growing evidence of immune dysfunction as a prominent feature of PTLD.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1607619","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T05:46:46Z","timestamp":1752126406000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Aberrant T-cell phenotypes in a cohort of patients with post-treatment Lyme disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Alexander A.","family":"Girgis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaello","family":"Cimbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison W.","family":"Rebman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thelio","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Villegas de Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Vadalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Darrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Soloski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Aucott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/art.38756","article-title":"Review: unraveling lyme disease","volume":"66","author":"Bockenstedt","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11136-012-0126-6","article-title":"Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here","volume":"22","author":"Aucott","year":"2013","journal-title":"Qual Life Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acy051","article-title":"Cognitive decline in post-treatment lyme disease syndrome","volume":"34","author":"Touradji","year":"2019","journal-title":"Arch Clin Neuropsychol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08906-w","article-title":"A review of post-treatment lyme disease syndrome and chronic lyme disease for the practicing immunologist","volume":"62","author":"Wong","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment lyme disease syndrome","volume":"4","author":"Rebman","year":"2017","journal-title":"Front Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00648-5","article-title":"Lyme arthritis: linking infection, inflammation and autoimmunity","volume":"17","author":"Lochhead","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit735","article-title":"Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans","volume":"58","author":"Strle","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00071-16","article-title":"CCL19 as a chemokine risk factor for posttreatment lyme disease syndrome: a prospective clinical cohort study","volume":"23","author":"Aucott","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.10.011","article-title":"Increased IFN\u03b1 activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits","volume":"255","author":"Jacek","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3201\/eid2906.221685","article-title":"Association of persistent symptoms after lyme neuroborreliosis and increased levels of interferon-\u03b1 in blood","volume":"29","author":"Hern\u00e1ndez","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1455","article-title":"Metabolic response in patients with post-treatment lyme disease symptoms\/syndrome","volume":"73","author":"Fitzgerald","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"ofx254","DOI":"10.1093\/ofid\/ofx254","article-title":"Risk factors for clinician-diagnosed lyme arthritis, facial palsy, carditis, and meningitis in patients from high-incidence states","volume":"5","author":"Kwit","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064110","article-title":"Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis","volume":"8","author":"Strle","year":"2013","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.47184","article-title":"Time to diagnosis and treatment of lyme disease by patient race","volume":"6","author":"Starke","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","article-title":"Surveillance for lyme disease - United States, 2008-2015","volume":"66","author":"Schwartz","year":"2017","journal-title":"Morb Mortal Wkly Rep Surveill Summ Wash DC"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S406466","article-title":"Does biological sex matter in lyme disease? The need for sex-disaggregated data in persistent illness","volume":"16","author":"Johnson","year":"2023","journal-title":"Int J Gen Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.01.033","article-title":"Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study","volume":"116","author":"Aucott","year":"2022","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-16438-0_12","article-title":"Sex and Gender Impact Lyme Disease Immunopathology, Diagnosis and Treatment","volume-title":"Sex and Gender Differences in Infection and Treatments for Infectious Diseases","author":"Rebman","year":"2015"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado2102","article-title":"Sex differences in postacute infection syndromes","volume":"16","author":"Silva","year":"2024","journal-title":"Sci Transl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2008.1193","article-title":"Implications of gender in chronic lyme disease","volume":"18","author":"Wormser","year":"2009","journal-title":"J Womens Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41467-024-45107-3","article-title":"Deep phenotyping of post-infectious myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"15","author":"Walitt","year":"2024","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040399","article-title":"Symptom heterogeneity and patient subgroup classification among US patients with post-treatment Lyme disease: an observational study","volume":"11","author":"Rebman","year":"2021","journal-title":"BMJ Open"},{"key":"B26","volume-title":"Lyme Disease (Borrelia burgdorferi) 2011 Case Definition","year":"2021"},{"key":"B27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","article-title":"Silhouettes: A graphical aid to the interpretation and validation of cluster analysis","volume":"20","author":"Rousseeuw","year":"1987","journal-title":"J Comput Appl Math"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v025.i04","article-title":"clValid: an R package for cluster validation","volume":"25","author":"Brock","year":"2008","journal-title":"J Stat Software"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188916","article-title":"Flow cytometric discrimination of seven lineage markers by using two fluorochromes","volume":"12","author":"Boin","year":"2017","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3109\/13813455.2012.705301","article-title":"Bio-Rad\u2019s Bio-Plex\u00ae suspension array system, xMAP technology overview","volume":"118","author":"Houser","year":"2012","journal-title":"Arch Physiol Biochem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ng1201-365","article-title":"Minimum information about a microarray experiment (MIAME)\u2014toward standards for microarray data","volume":"29","author":"Brazma","year":"2001","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Software"},{"key":"B34","volume-title":"Florian Hartig. DHARMa: Residual Diagnostics for Hierarchical (Multi-Level\/Mixed) Regression Models","author":"Hartig","year":"2024"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01810-6","article-title":"Unexplained post-acute infection syndromes","volume":"28","author":"Choutka","year":"2022","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00296","article-title":"CXCR5, the defining marker for follicular B helper T (TFH) cells","volume":"6","author":"Moser","year":"2015","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002828","article-title":"CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses","volume":"186","author":"Chevalier","year":"2011","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"102187","DOI":"10.1016\/j.coi.2022.102187","article-title":"CD4 T cell responses in persistent Borrelia burgdorferi infection","volume":"77","author":"Hammond","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1128\/IAI.02471-14","article-title":"CD4+ T Cells Promote Antibody Production but Not Sustained Affinity Maturation during Borrelia burgdorferi Infection","volume":"83","author":"Elsner","year":"2015","journal-title":"Infect Immun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01634","article-title":"Robust B cell responses predict rapid resolution of lyme disease","volume":"9","author":"Blum","year":"2018","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01844","article-title":"Maintenance of functional CD57+ Cytolytic CD4+ T cells in HIV+ Elite controllers","volume":"10","author":"Phetsouphanh","year":"2019","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1038\/s41598-018-21389-8","article-title":"STAT3 regulates cytotoxicity of human CD57+ CD4+ T cells in blood and lymphoid follicles","volume":"8","author":"Alshekaili","year":"2018","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1803-z","article-title":"CD57 in human natural killer cells and T-lymphocytes","volume":"65","author":"Kared","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.6.2928","article-title":"IFN-gamma and IL-4 regulate the growth and differentiation of CD8+ T cells into subpopulations with distinct cytokine profiles","volume":"155","author":"Noble","year":"1995","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.1.231","article-title":"Human Tc1 and Tc2\/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes","volume":"95","author":"Vukmanovic-Stejic","year":"2000","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01105-x","article-title":"CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential","volume":"55","author":"Koh","year":"2023","journal-title":"Exp Mol Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00949-7","article-title":"Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity","volume":"22","author":"Collier","year":"2021","journal-title":"Nat Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"a037796","DOI":"10.1101\/cshperspect.a037796","article-title":"Area under immunosurveillance: dedicated roles of memory CD8 T-cell subsets","volume":"12","author":"Parga-Vidal","year":"2020","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13075-015-0784-1","article-title":"Fatigue in chronic inflammation - a link to pain pathways","volume":"17","author":"Louati","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1561\/2200000008","article-title":"Clustering stability: an overview","volume":"2","author":"von Luxburg","year":"2009","journal-title":"Found Trends\u00ae Mach Learn"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1607619\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:37:24Z","timestamp":1752154644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1607619\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2025.1607619"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1607619","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"article-number":"1607619"}}